🇩🇪 DINUTUXIMAB BETA in Germany

DINUTUXIMAB BETA (DINUTUXIMAB BETA) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)
  • Status: approved

DINUTUXIMAB BETA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DINUTUXIMAB BETA approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for DINUTUXIMAB BETA in Germany?

Marketing authorisation holder not available in our data.